Cargando…

Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma

BACKGROUND: C-type lectin domain family 1 member B (CLEC1B, encoding the CLEC-2 protein), a member of the C-type lectin superfamily, is a type II transmembrane receptor involved in platelet activation, angiogenesis, and immune and inflammatory responses. However, data regarding its function and clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jing, Qiangan, Yuan, Chen, Zhou, Chaoting, Jin, Weidong, Wang, Aiwei, Wu, Yanfang, Shang, Wenzhong, Zhang, Guibing, Ke, Xia, Du, Jing, Li, Yanchun, Shao, Fangchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262401/ https://www.ncbi.nlm.nih.gov/pubmed/37308868 http://dx.doi.org/10.1186/s12935-023-02939-1

Ejemplares similares

CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Xing-Wei, et al.
Publicado: (2021)

CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Liang, Xiaoliang, et al.
Publicado: (2022)

Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis
por: Ren, Xueying, et al.
Publicado: (2021)

CDC25C is a prognostic biomarker and correlated with mitochondrial homeostasis in pancreatic adenocarcinoma
por: Zhou, Chaoting, et al.
Publicado: (2022)

Characterization of pyruvate metabolism and citric acid cycle patterns predicts response to immunotherapeutic and ferroptosis in gastric cancer
por: Wang, Xu, et al.
Publicado: (2022)

CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
por: Zhang, Yinjiang, et al.
Publicado: (2021)

CLEC14A was up-regulated in hepatocellular carcinoma and may function as a potential diagnostic biomarker
por: Yan, Lang, et al.
Publicado: (2022)

Downregulation of CISD2 Has Prognostic Value in Non-Small Cell Lung Cancer and Inhibits the Tumorigenesis by Inducing Mitochondrial Dysfunction
por: Shao, Fangchun, et al.
Publicado: (2021)

CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment
por: Sun, Jiaxing, et al.
Publicado: (2020)

Comprehensive Analysis to Identify the Encoded Gens of Sodium Channels as a Prognostic Biomarker in Hepatocellular Carcinoma
por: Yan, Yan, et al.
Publicado: (2022)

Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma
por: Wang, Xiaoqiang, et al.
Publicado: (2022)

DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism
por: Du, Jing, et al.
Publicado: (2021)

Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma
por: Shi, Yi, et al.
Publicado: (2021)

CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma
por: He, Min, et al.
Publicado: (2021)

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals
por: Dai, Wenjuan, et al.
Publicado: (2019)

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis
por: Chen, Rui, et al.
Publicado: (2022)

Autophagy-related prognostic signature characterizes tumor microenvironment and predicts response to ferroptosis in gastric cancer
por: Li, Haoran, et al.
Publicado: (2022)

CLEC2 and CLEC5A: Pathogenic Host Factors in Acute Viral Infections
por: Sung, Pei-Shan, et al.
Publicado: (2019)

Downregulated Expression of CLEC9A as Novel Biomarkers for Lung Adenocarcinoma
por: Miao, Fang, et al.
Publicado: (2021)

Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma
por: Ding, Lin, et al.
Publicado: (2022)

Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma
por: Qin, Zhongqiang, et al.
Publicado: (2023)

Comprehensive Analysis to Identify the Epithelial–Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma
por: Wu, Guozhi, et al.
Publicado: (2021)

Platelet CLEC‐2 and lung development
por: Suzuki‐Inoue, Katsue, et al.
Publicado: (2020)

CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma
por: Yu, Qianle, et al.
Publicado: (2020)

Genetic association analysis of CLEC5A and CLEC7A gene single-nucleotide polymorphisms and Crohn’s disease
por: Elleisy, Nagi, et al.
Publicado: (2020)

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
por: Zhang, Qifan, et al.
Publicado: (2021)

Editorial: Sentinel CLECs at Immunological Decision Nodes
por: Hoober, J. Kenneth, et al.
Publicado: (2020)

The Role of CLEC-2 and Its Ligands in Thromboinflammation
por: Meng, Danyang, et al.
Publicado: (2021)

Fidgetin as a potential prognostic biomarker for hepatocellular carcinoma
por: Zhou, Bin, et al.
Publicado: (2020)

Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
por: Fan, Yumei, et al.
Publicado: (2021)

Comprehensive Analysis to Identify SPP1 as a Prognostic Biomarker in Cervical Cancer
por: Zhao, Kaidi, et al.
Publicado: (2022)

Identification of an 11-Autophagy-Related-Gene Signature as Promising Prognostic Biomarker for Bladder Cancer Patients
por: Zhou, Chaoting, et al.
Publicado: (2021)

Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2
por: Herzog, Brett H., et al.
Publicado: (2013)

Integrated profiling identifies ITGB3BP as prognostic biomarker for hepatocellular carcinoma
por: Liang, Qiuli, et al.
Publicado: (2021)

Integrated Bioinformatic Analysis Identifies TIPIN as a Prognostic Biomarker in Hepatocellular Carcinoma
por: Chen, Hui, et al.
Publicado: (2022)

FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis
por: Hu, Wanye, et al.
Publicado: (2021)

Integrated bioinformatics analysis of potential pathway biomarkers using abnormal proteins in clubfoot
por: Cai, Guiquan, et al.
Publicado: (2020)

Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma
por: Chen, Rui, et al.
Publicado: (2021)

Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma
por: Dai, Weiyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pnm2n6sbjngb33gshpn026ksaf